Largest health care biotech companies by market cap
CRISPR Therapeutics has the lowest figure of the 24 health care biotech companies ranked by market value, at THB 132.3B, followed by Adaptive Biotechnologies (THB 156.4B) and Scholar Rock Holding (THB 198.8B). Figures as of 18 Nov 2026, 22:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR TherapeuticsTHB 132.3B
- Median
- THB 360.8B
- Combined market value
- THB 28.39T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Market cap ↑ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | THB 132.3B | THB 1,364.05 | 0.10% up | 21% down | ||
| 2 | Adaptive BiotechnologiesADPT · Health Care | THB 156.4B | THB 965.93 | 0.11% down | 88% up | ||
| 3 | Scholar Rock HoldingSRRK · Health Care | THB 198.8B | THB 1,629.12 | 6.48% up | 14% up | ||
| 4 | Kodiak SciencesKOD · Health Care | THB 217.1B | THB 3,319.67 | 1.04% up | 396% up | ||
| 5 | ImmunovantIMVT · Health Care | THB 233B | THB 1,125.79 | 0.12% down | 43% up | ||
| 6 | ImmunityBioIBRX · Health Care | THB 241.9B | THB 227.40 | 7.03% up | 193% up | ||
| 7 | CG OncologyCGON · Health Care | THB 242.5B | THB 2,715.20 | 1.34% up | 85% up | ||
| 8 | Twist BioscienceTWST · Health Care | THB 269.2B | THB 3,948.92 | 3.88% up | 340% up | ||
| 9 | VaxcytePCVX · Health Care | THB 314.4B | THB 1,986.17 | 1.48% down | 22% up | ||
| 10 | Krystal BiotechKRYS · Health Care | THB 317.2B | THB 10,702.64 | 5.62% up | 46% up | ||
| 11 | QiagenQGEN · Health Care | THB 347.3B | THB 1,682.07 | 0.38% down | 12% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | THB 351B | THB 4,111.15 | 0.32% down | 87% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | THB 370.7B | THB 3,251.45 | 0.18% down | 37% up | ||
| 14 | RepligenRGEN · Health Care | THB 374.6B | THB 5,860.42 | 6.47% up | 5% up | ||
| 15 | Bio-TechneTECH · Health Care | THB 387.9B | THB 2,469.13 | 0.17% up | 26% up | ||
| 16 | Neurocrine BiosciencesNBIX · Health Care | THB 559.5B | THB 5,527.47 | 1.84% down | 20% up | ||
| 17 | ExelixisEXEL · Health Care | THB 565.6B | THB 2,317.76 | 0.31% down | 63% up | ||
| 18 | BioNTechBNTX · Health Care | THB 700.6B | THB 2,825.84 | 1.89% down | 16% down | ||
| 19 | Revolution MedicinesRVMD · Health Care | THB 1.17T | THB 5,424.29 | 1.76% down | 131% up | ||
| 20 | BiogenBIIB · Health Care | THB 1.26T | THB 8,532.86 | 0.25% up | 49% up | ||
| 21 | argenxARGX · Health Care | THB 2.01T | THB 31,946.02 | 0.66% down | 4% up | ||
| 22 | ModernaMRNA · Health Care | THB 2.7T | THB 6,679.05 | 4.84% down | 755% up | ||
| 23 | Gilead SciencesGILD · Health Care | THB 7.11T | THB 5,735.18 | 0.75% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | THB 8.15T | THB 15,065.63 | 3.07% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9400 THB).
Questions and answers
Which health care biotech companies have the lowest market cap?
CRISPR Therapeutics (THB 132.3B), Adaptive Biotechnologies (THB 156.4B) and Scholar Rock Holding (THB 198.8B) have the lowest market cap of the 24 health care biotech companies ranked here as of 18 Nov 2026, 22:17 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by market value.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by market value have a combined market value of THB 28.39T as of 18 Nov 2026, 22:17 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care
Underlying data: Yahoo Finance; SEC EDGAR.